HIBL vs. LABU
Compare and contrast key facts about Direxion Daily S&P 500 High Beta Bull 3X Shares (HIBL) and Direxion Daily S&P Biotech Bull 3x Shares (LABU).
HIBL and LABU are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. HIBL is a passively managed fund by Direxion that tracks the performance of the S&P 500 High Beta Index (300%). It was launched on Nov 7, 2019. LABU is a passively managed fund by Direxion that tracks the performance of the S&P Biotechnology Select Industry Index (300%). It was launched on May 28, 2015. Both HIBL and LABU are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HIBL or LABU.
Key characteristics
| HIBL | LABU | |
|---|---|---|
| YTD Return | 16.01% | 18.67% |
| 1Y Return | 98.99% | 164.69% |
| 3Y Return (Ann) | -15.89% | -49.26% |
| 5Y Return (Ann) | 6.92% | -29.23% |
| Sharpe Ratio | 1.77 | 2.11 |
| Sortino Ratio | 2.21 | 2.58 |
| Omega Ratio | 1.29 | 1.30 |
| Calmar Ratio | 1.55 | 1.69 |
| Martin Ratio | 7.73 | 6.33 |
| Ulcer Index | 14.42% | 26.32% |
| Daily Std Dev | 62.91% | 79.08% |
| Max Drawdown | -88.27% | -98.92% |
| Current Drawdown | -43.33% | -96.85% |
Correlation
The correlation between HIBL and LABU is 0.55, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
HIBL vs. LABU - Performance Comparison
In the year-to-date period, HIBL achieves a 16.01% return, which is significantly lower than LABU's 18.67% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
HIBL vs. LABU - Expense Ratio Comparison
Both HIBL and LABU have an expense ratio of 1.12%.
Risk-Adjusted Performance
HIBL vs. LABU - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P 500 High Beta Bull 3X Shares (HIBL) and Direxion Daily S&P Biotech Bull 3x Shares (LABU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
HIBL vs. LABU - Dividend Comparison
HIBL's dividend yield for the trailing twelve months is around 0.93%, more than LABU's 0.36% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
HIBL Direxion Daily S&P 500 High Beta Bull 3X Shares | 0.93% | 0.69% | 0.00% | 0.06% | 0.19% | 0.19% | 0.00% | 0.00% |
LABU Direxion Daily S&P Biotech Bull 3x Shares | 0.36% | 0.35% | 0.00% | 0.00% | 0.00% | 0.28% | 0.64% | 0.17% |
Drawdowns
HIBL vs. LABU - Drawdown Comparison
The maximum HIBL drawdown since its inception was -88.27%, smaller than the maximum LABU drawdown of -98.92%. Use the drawdown chart below to compare losses from any high point for HIBL and LABU. For additional features, visit the drawdowns tool.
Volatility
HIBL vs. LABU - Volatility Comparison
Direxion Daily S&P 500 High Beta Bull 3X Shares (HIBL) has a higher volatility of 17.52% compared to Direxion Daily S&P Biotech Bull 3x Shares (LABU) at 14.69%. This indicates that HIBL's price experiences larger fluctuations and is considered to be riskier than LABU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.